| Company Name: |
ChemShuttle, Inc. |
| Tel: |
0510-83588313-811 18800520310 |
| Email: |
sales@chemshuttle.com |
4-(4-bromo-1H-pyrazol-3-yl)pyridine manufacturers
|
| | 4-(4-bromo-1H-pyrazol-3-yl)pyridine Basic information |
| Product Name: | 4-(4-bromo-1H-pyrazol-3-yl)pyridine | | Synonyms: | 4-(4-bromo-1H-pyrazol-3-yl)pyridine;4-(4-bromo-1H-pyrazol-5-yl)pyridine(SALTDATA: FREE);4-(4-Bromo-1h-pyrazol-3-yl)pyridin;Pyridine, 4-(4-bromo-1H-pyrazol-3-yl)-;181179;HDGFRP2/PSIP1-IN-1 | | CAS: | 166196-54-9 | | MF: | C8H6BrN3 | | MW: | 224.06 | | EINECS: | | | Product Categories: | | | Mol File: | 166196-54-9.mol |  |
| | 4-(4-bromo-1H-pyrazol-3-yl)pyridine Chemical Properties |
| Boiling point | 381.2±27.0 °C(Predicted) | | density | 1.651 | | storage temp. | 2-8°C | | form | Solid | | pka | 10.55±0.50(Predicted) |
| | 4-(4-bromo-1H-pyrazol-3-yl)pyridine Usage And Synthesis |
| Uses | HDGFRP2/PSIP1-IN-1 (compound BPP) is a dual inhibitor targeting the PWWP domain of hepatocarcinogenic growth factor-related protein 2 (HDGFRP2) and its homologous protein PSIP1, hinder the development and progression of diffuse intrinsic pontine glioma (DIPG). HDGFRP2/PSIP1-IN-1 binds to HDGFRP2 with a Kd value of 7 μM and a ligand efficiency of 0.47; it binds to the PSIP1 PWWP domain with a Kd value of 27 μM; meanwhile, it has a Kd value of 14 μM for HDGFRP3, indicating its effectiveness as an inhibitor of the HDGFRP2 PWWP subfamily[1]. | | References | [1] Xiaoli Wei, et al. Fragment-based discovery of small molecule inhibitors of the HDGFRP2 PWWP domain. FEBS Lett. 2024 Jul 19.1873-3468.14981. DOI:10.1002/1873-3468.14981 |
| | 4-(4-bromo-1H-pyrazol-3-yl)pyridine Preparation Products And Raw materials |
|